| Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease (NCT04284657) | University of Southern California | 2019-01-30 |
| A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) (NCT03825328) | Yanqiao Zhang | 2019-01-30 |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy (NCT03796962) | Xenon Pharmaceuticals Inc. | 2019-01-30 |
| A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis (NCT03727451) | Bellerophon | 2019-01-30 |
| Conservative Iron Chelation as a Disease-modifying Strategy in Amyotrophic Lateral Sclerosis (NCT03293069) | University Hospital, Lille | 2019-01-30 |
| PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC (NCT04144569) | Yongchang Zhang | 2019-01-30 |
| Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors (NCT03734588) | Spark Therapeutics, Inc. | 2019-01-30 |
| ModraDoc006/r in Patients With Breast Cancer (NCT03890744) | Modra Pharmaceuticals | 2019-01-30 |
| B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma (NCT03246750) | The Thai Lymphoma Study Group | 2019-01-30 |
| Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors (NCT03792724) | Clinica Universidad de Navarra, Universidad de Navarra | 2019-01-30 |
| Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer (NCT05850637) | Prevent Senior Institute | 2019-01-30 |
| A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCC (NCT03793725) | Yanqiao Zhang | 2019-01-30 |
| A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis (NCT03619902) | Vanda Pharmaceuticals | 2019-01-30 |
| [68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma (NCT03648073) | University of Alabama at Birmingham | 2019-01-30 |
| Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers (NCT03347838) | University of Colorado, Denver | 2019-01-30 |
| SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer (NCT03614949) | H. Lee Moffitt Cancer Center and Research Institute | 2019-01-29 |
| Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2 (NCT03284385) | National Cancer Institute (NCI) | 2019-01-29 |
| RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma (NCT03745430) | Hellenic Cooperative Oncology Group | 2019-01-29 |
| Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy (NCT02876094) | Hugh McMillan | 2019-01-29 |
| Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy (NCT03496805) | Wake Forest University Health Sciences | 2019-01-29 |
| FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma (NCT04393584) | Blokhin's Russian Cancer Research Center | 2019-01-29 |
| Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery (NCT03541850) | Jonsson Comprehensive Cancer Center | 2019-01-29 |
| Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma (NCT03761056) | Kite, A Gilead Company | 2019-01-29 |
| Dapagliflozin In Alzheimer's Disease (NCT03801642) | Jeff Burns, MD | 2019-01-29 |
| Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer (NCT03844620) | M.D. Anderson Cancer Center | 2019-01-29 |
| Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis (NCT03824392) | aTyr Pharma, Inc. | 2019-01-29 |
| Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6 (NCT03858894) | Santen Inc. | 2019-01-28 |
| Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac) (NCT03715985) | Herlev Hospital | 2019-01-28 |
| A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection (NCT03748992) | Medical University of South Carolina | 2019-01-28 |
| TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (NCT03860038) | TJ Biopharma Co., Ltd. | 2019-01-28 |
| Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection (NCT03820258) | Gilead Sciences | 2019-01-28 |
| A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies (NCT03829501) | Kymab Limited | 2019-01-28 |
| MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS) (NCT03846219) | Immunic AG | 2019-01-28 |
| Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma (NCT03646123) | Seagen Inc. | 2019-01-28 |
| Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma (NCT03654833) | University of Leicester | 2019-01-28 |
| Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer (NCT03734692) | Robert Edwards | 2019-01-28 |
| Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD) (NCT03782636) | University of Oxford | 2019-01-28 |
| Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma (NCT03598595) | M.D. Anderson Cancer Center | 2019-01-28 |
| TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma (NCT04059224) | Universitair Ziekenhuis Brussel | 2019-01-28 |
| RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study) (NCT03813641) | Shenzhen People's Hospital | 2019-01-28 |
| A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel (NCT03766581) | Bristol-Myers Squibb | 2019-01-27 |
| Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC (NCT03770455) | Jodi Layton, MD | 2019-01-25 |
| Vaccination of Triple Negative Breast Cancer Patients (NCT02938442) | University of Arkansas | 2019-01-25 |
| The POWERED Study: Prophylaxis With Metformin to Prevent PTDM (NCT05240274) | Barts & The London NHS Trust | 2019-01-25 |
| Vortioxetine for Treatment of Depressive Mood and Alcohol Use (NCT04498897) | Hanyang University Seoul Hospital | 2019-01-25 |
| Daratumumab, Bortezomib, and Dexamethasone With or Without Venetoclax in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT03701321) | National Cancer Institute (NCI) | 2019-01-25 |
| A Study of Semorinemab in Patients With Moderate Alzheimer's Disease (NCT03828747) | Genentech, Inc. | 2019-01-25 |
| Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia (NCT03735875) | M.D. Anderson Cancer Center | 2019-01-25 |
| Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults (NCT04173819) | International AIDS Vaccine Initiative | 2019-01-25 |
| Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension (NCT03720067) | Universidade Federal do Rio de Janeiro | 2019-01-25 |
| Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations (NCT03740100) | M.D. Anderson Cancer Center | 2019-01-25 |
| Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP] (NCT03747120) | University of Texas Southwestern Medical Center | 2019-01-25 |
| Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer (NCT03817411) | Taizhou EOC Pharma Co., Ltd. | 2019-01-25 |
| Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder (NCT04044664) | Aptinyx | 2019-01-25 |
| Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma (NCT03756896) | Emory University | 2019-01-25 |
| Benzodiazepines for the Reduction of Distress and Pain During and After Emergency Department Care (NCT03756038) | Maria Pacella | 2019-01-25 |
| Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants (NCT03589768) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-24 |
| Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer (NCT03329378) | Icahn School of Medicine at Mount Sinai | 2019-01-24 |
| A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine (NCT03803202) | GlaxoSmithKline | 2019-01-24 |
| Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer (NCT03801304) | University Hospital, Brest | 2019-01-24 |
| Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis) (NCT03786770) | Revance Therapeutics, Inc. | 2019-01-24 |
| Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) (NCT03739710) | GlaxoSmithKline | 2019-01-24 |
| Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study) (NCT03695510) | National Taiwan University Hospital | 2019-01-24 |
| A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis (NCT03844932) | Sublimity Therapeutics Holdco Limited | 2019-01-24 |
| Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM) (NCT03691727) | David Hasan | 2019-01-24 |
| Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation (NCT03983967) | GC Cell Corporation | 2019-01-24 |
| Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer (NCT04675697) | Xiangya Hospital of Central South University | 2019-01-24 |
| Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1 (NCT05553808) | GlaxoSmithKline | 2019-01-24 |
| Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial (NCT04535960) | University Health Network, Toronto | 2019-01-24 |
| Nicotinamide Riboside for Diabetic Neuropathy (NCT03685253) | University of Maryland, Baltimore | 2019-01-24 |
| Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas (NCT03783936) | Ashwin Somasundaram | 2019-01-24 |
| Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer (NCT02789878) | Instituto do Cancer do Estado de São Paulo | 2019-01-24 |
| Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes (NCT02846831) | Institut de Recherches Cliniques de Montreal | 2019-01-24 |
| Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines (NCT03806933) | Merz Aesthetics GmbH | 2019-01-23 |
| Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors (NCT03827837) | Jiangsu HengRui Medicine Co., Ltd. | 2019-01-23 |
| Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders (NCT05181748) | Genesis Athens Clinic | 2019-01-23 |
| Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10% (NCT03808480) | National Cancer Center, Korea | 2019-01-23 |
| A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma (NCT03758417) | Nanjing Legend Biotech Co. | 2019-01-23 |
| Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS) (NCT03624244) | Centre Leon Berard | 2019-01-23 |
| Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation Status (NCT03519412) | IFOM ETS - The AIRC Institute of Molecular Oncology | 2019-01-23 |
| Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma (NCT03761108) | Regeneron Pharmaceuticals | 2019-01-23 |
| A Clinical Study to Evaluate CAD-1883 in Essential Tremor (NCT03688685) | Cadent Therapeutics | 2019-01-23 |
| Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD (NCT03784963) | University of Chicago | 2019-01-23 |
| Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin (NCT03841331) | Vyne Therapeutics Inc. | 2019-01-22 |
| Nonopioid Analgesia After Rotator Cuff Repair (NCT03818919) | Henry Ford Health System | 2019-01-22 |
| Pegtibatinase as a Treatment for Patients With Classical Homocystinuria (HCU) (Also Known as the COMPOSE Study) (NCT03406611) | Travere Therapeutics, Inc. | 2019-01-22 |
| Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction (NCT03818932) | Henry Ford Health System | 2019-01-22 |
| Effects of Metformin in a Non-Diabetic Patient Population (NCT03772964) | Brian Zuckerbraun | 2019-01-22 |
| Nitrous Oxide for the Treatment of Major Depressive Disorder (NCT03869736) | Bayside Health | 2019-01-22 |
| Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis (NCT03672292) | Scynexis, Inc. | 2019-01-22 |
| Efficacy of Ocrelizumab in Autoimmune Encephalitis (NCT03835728) | University of Texas Southwestern Medical Center | 2019-01-22 |
| Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma (NCT03839498) | Columbia University | 2019-01-22 |
| Trial of Cannabis for Essential Tremor (NCT03805750) | University of California, San Diego | 2019-01-22 |
| CBT4CBT for Office Based Buprenorphine (NCT03580902) | CBT4CBT, LLC | 2019-01-22 |
| Exparel Interscalene vs Indwelling Catheter (NCT03827213) | Montefiore Medical Center | 2019-01-22 |
| Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial (NCT03553004) | University of Kansas Medical Center | 2019-01-22 |
| Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM (NCT06059326) | Haisco Pharmaceutical Group Co., Ltd. | 2019-01-22 |
| Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia (NCT03602053) | Centre for Infectious Disease Research in Zambia | 2019-01-22 |
| Nonopioid Analgesia After Labral Surgery (NCT03825809) | Henry Ford Health System | 2019-01-22 |
| Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients (NCT03781479) | Catalyst Pharmaceuticals, Inc. | 2019-01-21 |